CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 599,000 shares at an average $7.86 ($4,705,431)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 8,000 shares at $6.25 ($50,000)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $6.25 ($250,000)
- 4 Open-market buy General Counsel bought 1,600 shares at $6.25 ($10,000)
- 4 Open-market buy Director bought 8,000 shares at $6.25 ($50,000)
- 4 Open-market buy Director bought 3,200 shares at $6.25 ($20,000)
- 4 Open-market buy Director bought 4,000 shares at $6.25 ($25,000)
- 4 Open-market buy Chief Financial Officer bought 600 shares at $6.25 ($3,750)
- 4 Open-market buy Director bought 5,000 shares at $6.25 ($31,250)
- 4 Open-market buy Chief Medical Officer bought 1,600 shares at $6.25 ($10,000)
- 4 Shares withheld for taxes General Counsel gave up 3,396 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,459 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 5,498 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 16 · 314 filings